4//SEC Filing
Jones Mitchell Lawrence 4
Accession 0001493152-25-006500
CIK 0001357459other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:58 PM ET
Size
8.2 KB
Accession
0001493152-25-006500
Insider Transaction Report
Form 4
Jones Mitchell Lawrence
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2025-02-11+24,000→ 24,000 total→ Common Stock (24,000 underlying) - Award
Stock Option (Right to Buy)
2025-02-11+29,000→ 29,000 totalExercise: $1.13Exp: 2035-02-11→ Common Stock (29,000 underlying)
Footnotes (3)
- [F1]The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period with vesting commencing on May 11, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001993292
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:58 PM ET
- Size
- 8.2 KB